Pharmafile Logo
Pharmafocus logo
Advanced Search

restructure

Showing 10 posts of 25 posts found.

AstraZeneca to cut more jobs as sales stagnate

January 30, 2009
Sales and Marketing AZ, restructure

AstraZeneca's revenues will see virtually no growth in 2009, and the company has extended its cost cutting programme. Chief executive …

News

Roche to cut 780 production jobs

January 21, 2009
Manufacturing and Production Roche, restructure

Roche will shed 780 production jobs over the next two years as it continues to streamline its manufacturing operations, but …

News

BMS denies further 10% staff cut

January 2, 2009
Sales and Marketing BMS, restructure

Bristol Myers Squibb has denied claims it is making a further 10% reduction to its work force, and said any …

News

Pfizer cuts 700 jobs in France

December 17, 2008
Sales and Marketing France, Jobs, restructure

 Pfizer is to cut its workforce in France by axeing 700 jobs in order to reduce costs and counteract patent …

News

Lilly to reduce pipeline costs by a third

December 17, 2008
Research and Development lilly, restructure

Lilly aims to reduce the cost of it bringing new molecules to market by a third.The company's goal is to …

News

Sanofi appoints new finance head

December 11, 2008
Sales and Marketing Sanofi, restructure

Sanofi-Aventis' head of finance and legal affairs Jean-Claude Leroy is to leave the company as new chief executive Chris Viehbacher …

News

GSK plans research job losses in UK

October 3, 2008
Research and Development GSK, restructure

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

News

Sanofi look for stronger leadership in GSK’s Viehbacher

September 12, 2008
Sales and Marketing Sanofi, restructure

News

Lilly unveils streamlined business structure

May 22, 2008
Sales and Marketing lilly, restructure

A simplified and slimmed-down corporate structure has been unveiled by US pharmaceutical firm Lilly, which says it hopes to cut …

News

Stout to quit as GSK restructures

December 10, 2007
Sales and Marketing GSK, restructure

GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025